Tharimmune, Inc. (NASDAQ: THAR) has just priced a whopping $55 million underwritten offering to turbocharge its innovative Canton Coin treasury strategy.
$55 Million: Fueling Tharimmune’s Canton Coin Treasury Expansion
This biotech trailblazer, originally focused on battling inflammatory diseases, is now diving headfirst into the digital asset world. By leveraging Canton Coin on the privacy-powered Canton Network, Tharimmune is positioning itself as a pioneer in tokenizing traditional finance. The funds will amp up their digital asset holdings while supporting clinical programs – talk about a hybrid powerhouse!
Announced on January 20, 2026, the offering includes 1.8 million shares at $2.92 each and pre-funded warrants for up to 17 million more shares. It’s a clever move to build on their November 2025 $545 million raise that kickstarted this Canton-centric approach. If you’re following the crypto treasury wave, this echoes giants like MicroStrategy’s relentless Bitcoin accumulation or Bitmine’s Ethereum staking bonanza.
Breaking Down the Deal
Picture this: A company blending cutting-edge biotech with blockchain magic. Tharimmune’s strategy isn’t just holding crypto – it’s actively participating in the Canton Network, which already hosts trillions in on-chain assets. This $55 million infusion provides rocket fuel for expansion, plus everyday working capital. No wonder investors are buzzing!
As of this writing, THAR shares are trading at $3.04, up 4.11% from the previous close of $2.96, with volume spiking amid the news. Market cap sits around $102 million, showing plenty of room for growth in this volatile space.
How the Market Reacted When Others Did This
History loves a good crypto treasury tale. Remember when MicroStrategy dropped its first big Bitcoin bombshell in 2020? Their stock skyrocketed over 300% in months, turning heads and inspiring copycats. Tesla’s 2021 Bitcoin buy sent shares surging 20% in a day before the hype settled. More recently, Hyperscale Data’s Bitcoin treasury updates have kept their price on a rollercoaster ride, often popping double-digits on announcements. Bitmine’s Ethereum holdings reveal? A cool 15% jump as staking yields lured in bulls. These moves show markets dig bold treasury plays, but volatility is the name of the game – no crystal ball here, folks!
What’s Next for Tharimmune?
With this fresh capital, expect Tharimmune to double down on Canton Coin acquisitions and network validation. As corporate America warms up to crypto treasuries, THAR could be the underdog story of 2026. Stay tuned – this fusion of health tech and digital assets is just heating up!
